Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Virology

Relationships between Total Plasma Load of Torquetenovirus (TTV) and TTV Genogroups Carried

Fabrizio Maggi, Elisabetta Andreoli, Letizia Lanini, Claudia Fornai, Marialinda Vatteroni, Mauro Pistello, Silvano Presciuttini, Mauro Bendinelli
Fabrizio Maggi
Virology Section and Retrovirus Center, Department of Experimental Pathology, University of Pisa, Pisa, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisabetta Andreoli
Virology Section and Retrovirus Center, Department of Experimental Pathology, University of Pisa, Pisa, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Letizia Lanini
Virology Section and Retrovirus Center, Department of Experimental Pathology, University of Pisa, Pisa, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudia Fornai
Virology Section and Retrovirus Center, Department of Experimental Pathology, University of Pisa, Pisa, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marialinda Vatteroni
Virology Section and Retrovirus Center, Department of Experimental Pathology, University of Pisa, Pisa, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mauro Pistello
Virology Section and Retrovirus Center, Department of Experimental Pathology, University of Pisa, Pisa, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silvano Presciuttini
Virology Section and Retrovirus Center, Department of Experimental Pathology, University of Pisa, Pisa, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mauro Bendinelli
Virology Section and Retrovirus Center, Department of Experimental Pathology, University of Pisa, Pisa, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bendinelli@biomed.unipi.it
DOI: 10.1128/JCM.43.9.4807-4810.2005
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

In 239 torquetenovirus-positive people, multiple-genogroup infections were common and associated with higher viral loads than would be expected from simple additive effects. The latter observation was restricted to the infections which included both genogroups 1 and 3, pointing to the possible existence of some kind of infection facilitation between these genogroups.

Torquetenovirus (TTV), formerly known as TT virus, was discovered in 1997 by Japanese workers in the blood of a patient with cryptogenetic hepatitis and has since been shown to sustain long-term, possibly permanent viremia in a surprisingly high proportion (around 80%) of the general population worldwide (1-3, 5, 12, 13). It is also clearly documented that the loads of TTV (viral load [VL]) in plasma may differ extensively among individual hosts (15). Due to its high genetic heterogeneity, TTV is currently subdivided into five highly divergent genogroups, designated 1 to 5 (4, 14). Although multiple-genogroup TTV infections are quite frequent (1, 6, 7), there have been no reported studies on the possible relationships between the number of genogroups carried and the total VL present in an individual.

In the course of our studies, we noted that individuals with high VLs tended to yield more TTV genogroups than those with low VLs. Thus, in preliminary work, we examined whether this might be due to the fact that high VLs permitted detection of TTV genogroups which escaped detection in low-VL plasma because they represented a small fraction of the total VL. The experiments did not support this explanation. In particular, the processing of five low-VL plasma specimens that had yielded one or two TTV genogroups in such a way as to augment 10- and 100-fold the amount of DNA examined in the typing assays had little or no impact on the number of genogroups detected. Similarly, when five specimens positive for four genogroups and with VLs between 6.1 and 6.8 log10 copies per ml were diluted 100-fold, i.e., to a point where the VLs were in the range that is associated mostly with single-genogroup infections, they still yielded three to four TTV genogroups (data not shown).

Such failure to provide an easy explanation for the observation prompted a systematic look at the issue. To this purpose, we assessed the presence, load, and genogroup(s) of TTV in plasma samples from 300 people. The methods have been previously reported (8, 9, 15). Briefly, extracted DNA was assayed for TTV presence and load with a universal TaqMan real-time PCR having the potential to detect and quantitate all hitherto-recognized genetic forms of the virus (8, 9). TTV-positive DNA extracts were then typed with five distinct genogroup-specific PCRs, as described previously (8, 9), using the primer sets shown in Table 1.

TTV was detected in 267 people (89%) and successfully typed in 239. Most TTV-positives carried two distinct genogroups, followed by one, three, and four. TTV genogroups 1 and 3 were the most prevalent, followed at a distance by genogroups 4 and 5, while genogroup 2 was rather infrequent (Table 2). The failure to type TTV in the remaining 10% of the virus-positives was probably due to the lower sensitivity of the typing PCRs relative to the universal PCR (4,000 versus 1,000 DNA copies per ml), since the mean VL for this group of virus positives was 4.1 ± 0.9 log10 copies/ml compared to 5.1 ± 1.1 log10 copies/ml for those whose virus could be typed. However, the possible presence of TTV forms unrecognized by the typing protocol used cannot be excluded.

We then stratified the VLs of the 239 typed subjects according to the number of TTV genogroups they harbored (Fig. 1). Interestingly, on a log scale, the correlation between average VLs and numbers of TTV genogroups carried was linear, indicating an exponential increase in VL with an increasing number of genogroups harbored. Indeed, the VL increases were invariably greater than what would be expected based on simple additive effects: in dual-, triple-, and quadruple-genogroup infections, the average VLs were 5.0, 5.5, and 6.3 log10 copies/ml rather than 4.7, 4.9, and 5.0 log10 copies/ml, as would be expected from two-, three-, and fourfold increases, respectively, over those in the single-genogroup infections. Furthermore, breaking down the subjects into age, gender, or disease groups showed similar trends in the distribution of VL sizes, depending on the number of genogroups carried, thus corroborating the observation (data not shown).

We then examined whether the observation described above was unspecific or involved some particular genogroup combination(s) (Fig. 2). Single-genogroup-infected subjects showed no significant differences in mean VL, regardless of whether they carried genogroup 1, 3, or 4 (no single genogroup 2 infections were present in our series, and single genogroup 5 infections were too few for statistical analysis), thus showing that at least these genogroups are not inherently different in the viremia levels they establish when present alone. In contrast, analysis of the three categories of dually infected people that could be compared, namely, those infected with genogroups 1 and 3, 1 and 4, and 3 and 4 (the sizes of the other categories were too small for meaningful comparisons) showed that, on average, the VL was 10-fold higher in those coinfected by genogroups 1 and 3 than that in the pooled carriers of the other two combinations (P = 0.013; Student's t test). In addition, comparing the mean VLs of all single- and dual-genogroup infections yielded a significant heterogeneity (P < 0.001; analysis of variance test), and Tukey's multiple-comparison test showed that coinfection by genogroups 1 and 3 resulted in the only true outlier (P < 0.01). With regard to triple infections, we could compare only the VLs of those in whom both genogroups 1 and 3 were present with all the others; again, the mean VL was 10-fold higher in the former than in the latter, albeit the difference was not statistically significant, probably due to the small sample size.

In summary, these findings (i) confirm that multiple-genogroup TTV infections are quite common; (ii) demonstrate that in single-genogroup-infected individuals the TTV genogroups that could be evaluated produce comparable levels of viremia; and (iii) exclude the existence of major impediments between TTV genogroups that might stem from receptor-mediated interference, cross-immunity, or other causes. In addition, the results reveal that subjects coinfected with TTV of genogroups 1 and 3 tend to have higher-than-expected VLs. A possible explanation for this last finding is the existence of some kind of infection facilitation between these two genogroups, which might result from several mechanisms, including help at the cell level by transactivation or complementation or at the organism level by immunomodulation (9-11, 16) or antibody-mediated endocytosis. Such facilitation might help to explain the larger prevalence worldwide of genogroups 1 and 3 relative to other TTV genogroups. An alternative explanation is that the individuals carrying both genogroups 1 and 3 have particularly high VLs because they can become infected with especially numerous strains of TTV, due to the fact that these two genogroups not only are the most prevalent but also contain large arrays of viral genetic forms, including genotypes and species (4, 6, 14). Distinguishing between these possibilities will require an exhaustive evaluation, by cloning and sequencing, of the entire genetic diversity of the TTV present in large numbers of single- and multiple-genogroup-infected subjects.

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

VLs of the 239 subjects whose TTV infections proved typeable, stratified by the number of viral genogroups carried. VL is expressed as the mean log10 TTV DNA copies per ml of plasma ± confidence intervals (CI). The numbers in parentheses are numbers of patients in the respective groups. Statistical significance was calculated with the two-tailed, unpaired Student t test.

FIG. 2.
  • Open in new tab
  • Download powerpoint
FIG. 2.

VLs of the 239 subjects whose TTV infections proved typeable, stratified by the specific viral genogroup(s) carried. (Left panel) Single-genogroup infections; (central panel) dual-genogroup infections; (right panel) triple-genogroup infections. VL is expressed as described in the legend to Fig. 1. The numbers in parentheses are numbers of patients in the respective groups. Statistical comparisons were performed by the two-tailed, unpaired Student t test. Due to the small sample size, the group singly infected with genogroup 5 was excluded from analysis. The P values for significant differences are shown.

View this table:
  • View inline
  • View popup
TABLE 1.

PCR primers used for TTV genogrouping

View this table:
  • View inline
  • View popup
TABLE 2.

Number and identity of the TTV genogroups detected in the 239 study subjects whose infections proved typeablea

ACKNOWLEDGMENTS

This study was supported in part by Hardis within grant S454/P from the Ministero dell'Istruzione, dell'Università e della Ricerca, Rome, Italy.

FOOTNOTES

    • Received 1 March 2005.
    • Returned for modification 25 April 2005.
    • Accepted 2 June 2005.
  • Copyright © 2005 American Society for Microbiology

REFERENCES

  1. 1.↵
    Bendinelli, M., M. Pistello, F. Maggi, C. Fornai, G. Freer, and M. L. Vatteroni. 2001. Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans. Clin. Microbiol. Rev.14:98-113.
    OpenUrlAbstract/FREE Full Text
  2. 2.
    Biagini, P. 2004. Human circoviruses. Vet. Microbiol.98:95-101.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    Biagini, P., P. Gallian, M. Touinssi, J. F. Cantaloube, J. P. Zapitelli, X. de Lamballerie, and P. de Micco. 2000. High prevalence of TT virus infection in French blood donors revealed by the use of three PCR systems. Transfusion (Paris)40:590-595.
    OpenUrl
  4. 4.↵
    Devalle, S., and C. Niel. 2004. Distribution of TT virus genomic groups 1-5 in Brazilian blood donors, HBV carriers, and HIV-1-infected patients. J. Med. Virol.72:166-173.
    OpenUrlCrossRefPubMed
  5. 5.↵
    Hino, S. 2002. TTV, a new human virus with single stranded circular DNA genome. Rev. Med. Virol.12:151-158.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    Jelcic, I., A. Hotz-Wagenblatt, A. Hunziker, H. zur Hansen, and E.-M. de Villiers. 2004. Isolation of multiple TT virus genotypes from spleen biopsy tissue from a Hodgkin's disease patient: genome reorganization and diversity in the hypervariable region. J. Virol.78:7498-7507.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    Khudyakov, Y. E., M.-E. Cong, B. Nichols, D. Reed, X.-G. Dou, S. O. Viazov, J. Chang, M. W. Fried, I. Williams, W. Bower, S. Lambert, M. Purdy, M. Roggendorf, and H. A. Fields. 2000. Sequence heterogeneity of TT virus and closely related viruses. J. Virol.74:2990-3000.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    Maggi, F., M. Pifferi, C. Fornai, E. Andreoli, E. Tempestini, M. Vatteroni, S. Presciuttini, S. Marchi, A. Pietrobelli, A. Boner, M. Pistello, and M. Bendinelli. 2003. TT virus in the nasal secretions of children with acute respiratory diseases: relations to viremia and disease severity. J. Virol.77:2418-2425.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    Maggi, F., M. Pifferi, E. Tempestini, C. Fornai, L. Lanini, E. Andreoli, M. Vatteroni, S. Presciuttini, A. Pietrobelli, A. Boner, M. Pistello, and M. Bendinelli. 2003. TT virus loads and lymphocyte subpopulations in children with acute respiratory diseases. J. Virol.77:9081-9083.
    OpenUrlAbstract/FREE Full Text
  10. 10.
    Mariscal, L. F., J. M. Lopez-Alcorocho, E. Rodriguez-Inigo, N. Ortiz-Movilla, S. de Lucas, J. Bartolome, and V. Carreno. 2002. TT virus replicates in stimulated but not in nonstimulated peripheral blood mononuclear cells. Virology301:121-129.
    OpenUrlCrossRefPubMed
  11. 11.↵
    Moen, E. M., S. Sagedal, K. Bjoro, M. Degre, P. K. Opstad, and B. Grinde. 2003. Effect of immune modulation on TT virus (TTV) and TTV-like mini-virus (TLMV) viremia. J. Med. Virol.70:177-182.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    Nishizawa, T., H. Okamoto, K. Konishi, H. Yoshizawa, Y. Miyakawa, and M. Mayumi. 1997. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem. Biophys. Res. Commun.241:92-97.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    Okamoto, H., and M. Mayumi. 2001. TT virus: virological and genomic characteristics and disease associations. J. Gastroenterol.36:519-529.
    OpenUrlCrossRefPubMed
  14. 14.↵
    Peng, Y. H., T. Nishizawa, M. Takahashi, T. Ishikawa, A. Yoshikawa, and H. Okamoto. 2002. Analysis of the entire genomes of thirteen TT virus variants classifiable into the fourth and fifth genetic groups, isolated from viremic infants. Arch. Virol.147:21-41.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    Pistello, M., A. Morrica, F. Maggi, M. L. Vatteroni, G. Freer, C. Fornai, F. Casula, S. Marchi, P. Ciccorossi, P. Rovero, and M. Bendinelli. 2001. TT virus levels in the plasma of infected individuals with different hepatic and extrahepatic pathologies. J. Med. Virol.63:189-195.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    Shibayama, T., G. Masuda, A. Ajisawa, M. Takahashi, T. Nishizawa, F. Tsuda, and H. Okamoto. 2001. Inverse relationship between the titre of TT virus DNA and the CD4 cell count in patients infected with HIV. AIDS15:563-570.
    OpenUrlCrossRefPubMed
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Relationships between Total Plasma Load of Torquetenovirus (TTV) and TTV Genogroups Carried
Fabrizio Maggi, Elisabetta Andreoli, Letizia Lanini, Claudia Fornai, Marialinda Vatteroni, Mauro Pistello, Silvano Presciuttini, Mauro Bendinelli
Journal of Clinical Microbiology Sep 2005, 43 (9) 4807-4810; DOI: 10.1128/JCM.43.9.4807-4810.2005

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Relationships between Total Plasma Load of Torquetenovirus (TTV) and TTV Genogroups Carried
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Relationships between Total Plasma Load of Torquetenovirus (TTV) and TTV Genogroups Carried
Fabrizio Maggi, Elisabetta Andreoli, Letizia Lanini, Claudia Fornai, Marialinda Vatteroni, Mauro Pistello, Silvano Presciuttini, Mauro Bendinelli
Journal of Clinical Microbiology Sep 2005, 43 (9) 4807-4810; DOI: 10.1128/JCM.43.9.4807-4810.2005
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Carrier State
Circoviridae Infections
plasma
Torque teno virus
viral load

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X